FDA approves Taro’s acne generic

ROCKVILLE, Md. The Food and Drug Administration has approved a generic version of an acne drug.

The agency approved Taro Pharmaceutical Industries’ sulfacetamide sodium lotion in the 10% strength.

The lotion is a generic version of Sanofi-Aventis’ Klaron. Klaron and its generic equivalents had sales of approximately $15 million for the 12 months ended March 31, according to Taro.